Evidence map›Paper›PMID 24813204›Full record

Trial reportJournal of immunology (Baltimore, Md. : 1950)2014

IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells.

Jonathan P Huber, Sarah R Gonzales-van Horn, Kole T Roybal, Michelle A Gill, J David Farrar

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Histone modifications and their role in epigenetics of atopy and allergic diseases.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2018
    Review
  12. Review
  13. DNA methylation of Th2 lineage determination genes at birth is associated with allergic outcomes in childhood.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2017
    Article
  14. Article
  15. Article
  16. Review
  17. Maternal obesity alters immune cell frequencies and responses in umbilical cord blood samples.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2015
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jonathan P HuberDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390; and.
Sarah R Gonzales-van HornDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390; and.
Kole T RoybalDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390; and.
Michelle A GillDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390.
J David FarrarDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390; and David.Farrar@UTSouthwestern.edu.
The University of Texas Southwestern Medical Center · US

Funding

INTEGRATIVE IMMUNOLOGY TRAINING PROGRAMT32AI005284 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Nan Yan · 2003 to 2026
$7.4M
Type I Interferon-Regulated T Helper DevelopmentR01AI056222 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI FARRAR, JOHN DAVID · 2005 to 2014
$3.8M
Effect of Atopy on Dendritic Cell Antiviral ResponsesR01AI098077 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GILL, MICHELLE A · 2011 to 2013
$1.2M
Role of Type I Interferon in Allergic AsthmaF31AI094800 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GONZALES-VAN HORN, SARAH RUTH · 2012 to 2014
$83k
NIAID NIH HHS F31 AI094800NIAID NIH HHS R01 AI056222NIAID NIH HHS R01 AI098077NIAID NIH HHS T32 AI005284PHS HHS AIF31094800PHS HHS AIR0156222PHS HHS AIT32005284
6 · The paper itself

Abstract

CD4(+) Th2 development is regulated by the zinc finger transcription factor GATA3. Once induced by acute priming signals, such as IL-4, GATA3 poises the Th2 cytokine locus for rapid activation and establishes a positive-feedback loop that maintains elevated GATA3 expression. Type I IFN (IFN-α/β) inhibits Th2 cells by blocking the expression of GATA3 during Th2 development and in fully committed Th2 cells. In this study, we uncovered a unique mechanism by which IFN-α/β signaling represses the GATA3 gene in human Th2 cells. IFN-α/β suppressed expression of GATA3 mRNA that was transcribed from an alternative distal upstream exon (1A). This suppression was not mediated through DNA methylation, but rather by histone modifications localized to a conserved noncoding sequence (CNS-1) upstream of exon 1A. IFN-α/β treatment led to a closed conformation of CNS-1, as assessed by DNase I hypersensitivity, along with enhanced accumulation of H3K27me3 mark at this CNS region, which correlated with increased density of total nucleosomes at this putative enhancer. Consequently, accessibility of CNS-1 to GATA3 DNA binding activity was reduced in response to IFN-α/β signaling, even in the presence of IL-4. Thus, IFN-α/β disrupts the GATA3-autoactivation loop and promotes epigenetic silencing of a Th2-specific regulatory region within the GATA3 gene.

Indexed as

AdultDNA MethylationEnhancer Elements, GeneticExonsFemaleGATA3 Transcription FactorHumansInterferon-alphaInterferon-betaInterleukin-4MaleSignal TransductionTh2 CellsTranscription, GeneticGATA3 protein, humanGATA3 Transcription FactorIL4 protein, humanInterferon-alphaInterferon-betaInterleukin-4

Identifiers

PMID24813204
PMCPMC4104489
OpenAlexW2158846398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.